Julius Popp - Concepedia

Author

Julius Popp

Also Known As

Carole Dufouil, Daniel Alcolea, Edna Grünblatt, Isabel Sala, J Popp, J. Popp, Jordi Pérez-Tur, Judes Poirier, Julius Popp, Philip Scheltens

277

Publications

13.4K

Citations

H-Index

100

Concepts

All Affiliations

University Hospital of Lausanne University of Lausanne University of Gothenburg University Hospital of Zurich University of Bonn

About

Julius Popp is an author at University Hospital of Lausanne specializing in medicine, neurology, and alzheimer's disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	29	2.4K
2	Health Sciences	8	8	492
3	Social Sciences	5	5	454
4	Public Health	3	3	115
5	Biochemistry	2	2	113

Julius Popp

111

Publications

10K

Citations

H-Index

Page 1

	Year	Citations
New insights into the genetic etiology of Alzheimer’s disease and related dementias Céline Bellenguez, Fahri Küçükali, Iris E. Jansen, Nature Genetics	2022	2.3K
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores Itziar de Rojas, Sonia Moreno–Grau, Niccoló Tesi, Nature Communications	2021	320
Blood‐brain barrier breakdown, neuroinflammation, and cognitive decline in older adults Gene L. Bowman, Richard Kirkland, Jérôme Wojcik, Alzheimer s & Dementia	2018	281
Glucose metabolism, gray matter structure, and memory decline in subjective memory impairment Lukas Scheef, Annika Spottke, Moritz Daerr, Neurology	2012	271
Systemic and central nervous system metabolic alterations in Alzheimer’s disease Vera van der Velpen, Tony Teav, Héctor Gallart‐Ayala, Alzheimer s Research & Therapy	2019	247
Validity and Reliability of the CAM-ICU Flowsheet to diagnose delirium in surgical ICU patients Ulf Guenther, Julius Popp, Lena Koecher, Journal of Critical Care Surgical Icu PatientsCam-icu FlowsheetAcute CarePatient SafetyDiagnosis	2009	213
Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomics Betty M. Tijms, Johan Gobom, Lianne M. Reus, Brain Subtype 1Neurochemical BiomarkersSocial SciencesProteomic TechnologyDisease Heterogeneity	2020	212
Inflammatory biomarkers in Alzheimer's disease plasma Angharad R. Morgan, Samuel Touchard, Claire A. Leckey, Alzheimer s & Dementia	2019	201
Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial Richard Dodel, Axel Rominger, Peter Bartenstein, The Lancet Neurology Geriatric NeurologyAlzheimer's DiseaseMedicineDementiaIntravenous Immunoglobulin	2013	183
Volume Loss of the Medial Temporal Lobe Structures in Subjective Memory Impairment Nadine Striepens, Lukas Scheef, Andrea Wind, Dementia and Geriatric Cognitive Disorders	2010	181

Page 1